HOLLYWOOD, FL - AUGUST 24: In this photo illustration, EpiPen, which dispenses epinephrine through an injection mechanism for people with severe allergies, is seen as the company that makes it Mylan Inc. has come under fire from consumers and lawmakers for the price that it is currently charging on August 16, 2016 in Hollywood, Florida. Reports indicate that the cost of a pair of EpiPens has risen 400 percent from when the Mylan acquired the original company in 2007. (Photo Illustration by Joe Raedle/Getty Images)

The manufacturer of EpiPen devices failed to address known malfunctions in its epinephrine auto-injectors even as hundreds of customer complaints rolled in and failures were linked to deaths, according to the Food and Drug Administration.
The damning allegations came to light today when the FDA posted a warning letter it sent September 5 to the manufacturer, Meridian Medical Technologies, Inc. The company (which is owned by Pfizer) produces EpiPens for Mylan, which owns the devices and is notorious for dramatically raising prices by more than 400 percent in recent years.
The auto-injectors are designed to be used during life-threatening allergic reactions to provide a quick shot of epinephrine. If they fail to fire, people experiencing a reaction can die or suffer serious illnesses. According to the FDA, that’s exactly what happened for hundreds of customers.
In the letter, the agency wrote:
The agency goes on to lambast Meridian Medical for failing to investigate problems …
READ MORE ON ARSTECHNICA.COM